Frank Bellivier received his medical degree at the University of Paris (René Descartes). His current roles include Professor of Adult Psychiatry at University Denis Diderot in Paris, Head of the Departments of Psychiatry and Addiction at Saint-Louis - Lariboisière – F. Widal hospitals in Paris.

He is also director of a research team on neuropsychopharmacology of bipolar disorders and addictions at the Institut National de la Santé et de la Recherche Médicale.

Professor Bellivier’s principal research interest relates to understanding the molecular basis of bipolar disorder and its treatment. His research is particularly focused on the genetic vulnerability factors in bipolar disorder and suicidal behaviors.

Professor Bellivier has led several large clinical programmes for patients with mood disorders, including the Early Onset Bipolar Disorders Program, funded by the INSERM, ANR and the Assistance Publique Hôpitaux de Paris (APHP).

He received several research prizes: University Paris 12 Research Prize (2000), the Jules Baillarger Prize (2002) and the NARSAD Independent Investigator Award (2004). For the research program on biomarkers of lithium response, the National Research Agency (ANR générique), the Sorbonne Paris Cité University, the French Ministry of Research (PHRC) and the FondaMental/Dassault Fondations Research Prize (2013) fund his team. In September 2015, he set-up the R-LiNK project, a European consortium project on biomarkers of Lithium response. This project has received funding from The European Union’s Horizon 2020 Research and Innovation Programme Under Grant Agreement N° 754907.

In May 2019 Frank Bellivier was appointed Ministerial Delegate for Mental Health and Psychiatry at the Ministry of Health and Prevention in charge of the governmental roadmap for mental health and psychiatry.